Hematology Oncology Associates of South Jersey is a clinical research site located in Mount Holly, New Jersey, United States 08060.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Hematology Oncology Associates of South Jersey has participated in 2 clinical trials.
Therapeutic areas: Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL), Prostate Cancer.
Sponsors: Millennium Pharmaceuticals, Inc., Celgene.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Hematology Oncology Associates of South Jersey has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Hematology Oncology Associates of South Jersey has 2 clinical trials on record. Their work covers Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL), Prostate Cancer.
Hematology Oncology Associates of South Jersey has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.